{"3": ["diagnosis of either aMCI or mild AD. "], "2": ["18 F] fluorodeoxyglucose (FDG); the PET-FDG ", "In the present study, we tested the hypothesis that a newly-developed multicomponent cognitive interven- tion [12] applied in a randomized controlled trial would lead to cognitive and non-cognitive benefits and mit- igate against declining brain metabolism in patients with amnestic MCI or mild AD ", "43 patients "]}